Niki BioSolutions, Inc. (NIKI) insider reports 1,515,293-share stake

Rhea-AI Filing Summary

Niki BioSolutions, Inc. director and more-than-10% owner Sheinerman Kira reported beneficial ownership of 1,515,293 shares of Common Stock. Of these, 1,515,016 shares are held directly and 277 shares are held in a joint brokerage account with shared voting and dispositive power.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Sheinerman Kira

Role Director, 10% Owner

Type	Security	Shares	Price	Value
holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 1,515,293 shares (Direct)

Key Figures

Total shares beneficially owned: 1,515,293 shares Directly held shares: 1,515,016 shares Joint brokerage account shares: 277 shares

3 metrics

Total shares beneficially owned 1,515,293 shares Common Stock beneficially owned by Sheinerman Kira following the reported holdings

Directly held shares 1,515,016 shares Common Stock held directly by the reporting person

Joint brokerage account shares 277 shares Shares in a joint brokerage account with shared voting and dispositive power

Key Terms

Common Stock, joint brokerage account, voting and dispositive power, ten percent owner

4 terms

Common Stock financial

"security_title: "Common Stock""

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

joint brokerage account financial

"277 shares are held in a joint brokerage account, over which the Reporting Person"

voting and dispositive power financial

"over which the Reporting Person may be deemed to share voting and dispositive power"

ten percent owner financial

"is_ten_percent_owner: 1"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Understanding Insider Trading Forms →

Available on EDGAR 07/24/2026 - 04:30 PM Accepted by SEC EDGAR 07/24/2026 - 04:30 PM Learn about SEC filing dates

FAQ

What insider ownership does Niki BioSolutions, Inc. (NIKI) report for Sheinerman Kira?

Sheinerman Kira reports beneficial ownership of 1,515,293 shares of Niki BioSolutions, Inc. Common Stock, combining direct holdings and shares in a joint brokerage account where voting and dispositive power are shared.

How many Niki BioSolutions, Inc. (NIKI) shares does Sheinerman Kira hold directly?

Sheinerman Kira directly holds 1,515,016 shares of Niki BioSolutions, Inc. Common Stock. These shares are separate from the smaller position held in a joint brokerage account that involves shared voting and dispositive power.

How many Niki BioSolutions, Inc. (NIKI) shares are in Sheinerman Kira's joint brokerage account?

Sheinerman Kira has 277 shares of Niki BioSolutions, Inc. Common Stock in a joint brokerage account. For these shares, the reporting person may be deemed to share voting and dispositive power with the joint account holder.

Why is Sheinerman Kira classified as a more-than-10% owner of Niki BioSolutions, Inc. (NIKI)?

Sheinerman Kira is identified as a more-than-10% owner, a status that, along with being a director, triggers insider reporting obligations. This classification requires filing Form 3 to disclose current beneficial ownership of Niki BioSolutions, Inc. Common Stock.

Does the Form 3 for Niki BioSolutions, Inc. (NIKI) show any recent insider share purchases or sales by Sheinerman Kira?

The Form 3 reports holdings only, with no purchase or sale transactions listed. It provides an initial snapshot of Sheinerman Kira’s beneficial ownership of Niki BioSolutions, Inc. Common Stock rather than documenting new trading activity.

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Sheinerman Kira

(Last) (First) (Middle)

C/O NIKI BIOSOLUTIONS, INC.

116 VILLAGE BOULEVARD, SUITE 200

(Street)

PRINCETON NEW JERSEY 08540

(City) (State) (Zip)

UNITED STATES

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
07/20/2026

3. Issuer Name and Ticker or Trading Symbol
Niki BioSolutions, Inc. [ NIKI ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	X	10% Owner
	Officer (give title below)		Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	1,515,293	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

1,515,016 shares are held directly by the Reporting Person and 277 shares are held in a joint brokerage account, over which the Reporting Person may be deemed to share voting and dispositive power.

	/s/ Kira S. Sheinerman	07/24/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)